Novel RNA Molecule Linked to Cancer Survival Rates

Researchers discover non-coding RNA that supports nucleolus structure and function, with implications for blood cancer prognosis.

Feb. 3, 2026 at 3:55am

Got story updates? Submit your updates here. ›

Researchers at the Texas A&M University Health Science Center have identified a novel non-coding RNA molecule, named CUL1-IPA, that originates from the CUL1 protein-coding gene. This RNA plays a crucial role in preserving the integrity and activity of the nucleolus, an essential cellular structure for ribosome production. The study also found that higher levels of CUL1-IPA correlate with poorer survival outcomes in certain blood cancers, suggesting it may serve as a biomarker or therapeutic target.

Why it matters

This discovery challenges the conventional understanding of how genes function, showing that a single gene can produce multiple RNA molecules with distinct roles. Non-coding RNAs like CUL1-IPA that support essential cellular structures like the nucleolus could be important for cancer progression, making them potential biomarkers or therapeutic targets.

The details

The researchers found that removing CUL1-IPA from living cells caused the nucleolus to break apart, demonstrating its importance in maintaining the structural integrity of this crucial organelle. Further analysis of patient data from multiple myeloma and chronic lymphocytic leukemia revealed that higher levels of CUL1-IPA correlated with more aggressive forms of these blood cancers and poorer patient survival, regardless of the levels of the traditional CUL1 protein-coding RNA.

  • The study was published in the Proceedings of the National Academy of Sciences (PNAS) in February 2026.

The players

Dr. Irtisha Singh

Senior author of the study and researcher at the Texas A&M Naresh K. Vashisht College of Medicine.

Dr. Sumana Mallick

Co-first author of the study.

Dr. Pranita Borkar

Co-first author of the study.

Texas A&M University Health Science Center

The institution where the research was conducted.

Proceedings of the National Academy of Sciences (PNAS)

The scientific journal where the study was published.

Got photos? Submit your photos here. ›

What they’re saying

“This finding redefines the conventional assumption that protein-coding genes produce only protein-related messages.”

— Dr. Irtisha Singh, Senior author of the study

“We were amazed at how essential this RNA turned out to be. Removing it caused the nucleolus to lose its structural integrity, making it clear that non-coding RNAs from protein-coding genes can play central regulatory roles.”

— Dr. Sumana Mallick, Co-first author of the study

“Its expression correlates with patient survival in blood cancers and may contribute to how aggressive these cancers become.”

— Dr. Pranita Borkar, Co-first author of the study

What’s next

Researchers plan to further investigate the role of CUL1-IPA in cancer progression and explore its potential as a biomarker or therapeutic target.

The takeaway

This discovery challenges the conventional understanding of gene function and highlights the importance of non-coding RNAs in regulating essential cellular processes. The findings have significant implications for our understanding of cancer biology and the development of new diagnostic and treatment approaches.